Preventing Rheumatoid Arthritis-Associated Interstitial Lung Disease Through Subclinical Pulmonary Biomarker Surveillance

Speciality: Rheumatology

Description:

Welcome to today’s episode, where we explore an emerging approach to prevent interstitial lung disease, or ILD, in patients with rheumatoid arthritis. ILD is a serious complication that can develop silently alongside rheumatoid arthritis, often going undetected until significant lung damage occurs. Researchers are now focusing on subclinical pulmonary biomarker surveillance—regularly monitoring blood markers that indicate early lung involvement before symptoms appear. This proactive strategy enables doctors to identify at-risk patients sooner and intervene with targeted therapies, potentially slowing or even preventing ILD progression. By embracing biomarker surveillance, we can offer new hope for preserving lung health in rheumatoid arthritis patients. Stay tuned for more insights on innovations in autoimmune disease care.

See More Webinars @ Hidoc Webinars